[Lamivudine treatment of patients with decompensated HBV cirrhosis and mutation in YMDD motif].
Wei
Lai
L
Peking University People's Hospital, Peking University Hepatology Institute, Beijing 100044, China. weelai@163.com
D020816:Amino Acid Motifs / Q000235:genetics; D005260:Female; D006515:Hepatitis B virus / Q000235:genetics*; D019694:Hepatitis B, Chronic / Q000150:complications / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*; D008103:Liver Cirrhosis / Q000188:drug therapy* / Q000209:etiology / Q000821:virology; D008297:Male; D017354:Point Mutation; D012194:RNA-Directed DNA Polymerase / Q000235:genetics; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use
D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine; D012194:RNA-Directed DNA Polymerase